KURA vs REGN: Which Stock is Better?
Side-by-side comparison of Kura Oncology Inc and Regeneron Pharmaceuticals Inc in 2026
KURA
Kura Oncology Inc
$9.68
REGN
Regeneron Pharmaceuticals Inc
$750.57
Key Metrics Comparison
| Metric | KURA | REGN | Winner |
|---|---|---|---|
| Market Cap | $793.54M | $78.87B | REGN |
| P/E Ratio | N/A | 17.98 | REGN |
| EPS (TTM) | $N/A | $41.48 | REGN |
| Revenue Growth | -0.7% | 0.0% | REGN |
| Gross Margin | -272.1% | 44.6% | REGN |
Analyze KURA
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KURA or REGN a better investment?
Comparing KURA and REGN: Kura Oncology Inc has a market cap of $793.54M while Regeneron Pharmaceuticals Inc has $78.87B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KURA and REGN?
KURA (Kura Oncology Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KURA or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: KURA or REGN?
REGN has higher revenue growth at 0.0% vs -0.7% for KURA.
Which company is more profitable: KURA or REGN?
Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to -272.1% for KURA.
Which is the larger company: KURA or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $78.87B compared to $793.54M for KURA.
Should I buy KURA or REGN in 2026?
Both KURA and REGN have investment merit. KURA trades at $9.68 while REGN trades at $750.57. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KURA and REGN stock?
Key differences: Market Cap ($793.54M vs $78.87B), P/E Ratio (N/A vs 18.0x), Revenue Growth (-0.7% vs 0.0%), Gross Margin (-272.1% vs 44.6%).